BUSINESS
Sun Pharma seeks marketing approval from European regulator for psoriasis drug
In July 2016, Almirall entered into a licensing agreement with Sun Pharma for the development and commercialisation of tildrakizumab for psoriasis in Europe.
HEALTH-TRENDS
RS passes HIV-AIDS bill to penalise discrimination, make treatment obligatory
The bill lays down penal provisions for any discrimination practised against a person with HIV/AIDS and breach of confidentiality.
BUSINESS
'Even in US and Europe, we haven't seen such orchestrated action by pharma cos'
In an interview to Moneycontrol, David Keeling of McKinsey & Co says Indian pharmaceutical companies have made a lot of progress in terms of quality control, but there is still a long way to go.
BUSINESS
New e-platform to help India weed out substandard drugs
Unlike the US and Europe, India does not currently have a tracking system for the drug supply chain.
BUSINESS
Sun Pharma buys Bellus Health arm, gets rights to its experimental kidney drug
Shigamab is a monoclonal antibody therapy being developed for the treatment of Hemolytic Uremic Syndrome caused by Shiga toxin-producing E. coli (sHUS), a rare disease that principally affects the kidneys and often leads to patients requiring acute dialysis.
BUSINESS
Lupin gets US regulator nod for generic oral contraceptive Minastrin 24 Fe
Lupin has received approvals for eight products since January this year and has launched seven products including this one.
BUSINESS
Why Scott Gottlieb, the new US FDA chief, could be good news for Indian drug makers
The US FDA appointment is closely watched by Indian pharmaceutical industry which supplies 40 percent of the generic medications consumed in the US. The generic or copycat drugs account for more than 8 in 10 prescriptions. India has 572 US FDA compliant plants -- the highest outside US.
